Category: Boehringer Ingelheim

The Accept Phase Ib/II Single Arm Study

Oral and Poster Abstracts 626. Aggressive Lymphomas: Prospective Therapeutic Trials: Poster III Research, clinical trials, Lymphomas, Clinical Research, Combination therapy, Diseases, aggressive lymphoma, Therapies, Lymphoid Malignancies Andrew J Davies, BSc, BM, FRCP, PhD1,2*, Josh Caddy, BSc3*, Katy McLaughlin, BSc3*, Christopher Wignall, MSc3*, Robert…

Continue Reading The Accept Phase Ib/II Single Arm Study

Global Fibroblast Growth Factor Receptor 2 market key industry players and their market scope 2022

Pune, Maharashtra, India, September 22 2022 (Wiredrelease) Marke.biz–:The research provides the Global Fibroblast Growth Factor Receptor 2 Market aims at leveraging the insights and perspectives derived based on both qualitative and quantitative data evaluations for the forecast period, 2022-2030. The use of the technology for malady wipeout through direct correction of disturbances…

Continue Reading Global Fibroblast Growth Factor Receptor 2 market key industry players and their market scope 2022

Breaking down proteins: How starving cancer c

Cancer cells often grow in environments that are low in nutrients, and they cope with this challenge by switching their metabolism to using proteins as alternative “food”. Building on genetic screens, an international team of scientists could identify the protein LYSET as part of a pathway that allows cancer cells…

Continue Reading Breaking down proteins: How starving cancer c

Sahar Esmaeeli, PhD on LinkedIn: Data Scientist – Statistical Geneticist

Are looking for a company that allows you to do meaningful work that has a positive impact on healthcare? With all the economic uncertainty are you focused on a company that is consistently profitable and is continuing to grow? Check us out! Apixio has a great opportunity for a Data…

Continue Reading Sahar Esmaeeli, PhD on LinkedIn: Data Scientist – Statistical Geneticist

Senior Scientist – Clinical Bioinformatics and Data Science (m/w/d)

OUR COMPANY At Boehringer Ingelheim we develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company, we focus on long-term performance. We believe that if we have talented and ambitious people who are passionate about innovation, there is no…

Continue Reading Senior Scientist – Clinical Bioinformatics and Data Science (m/w/d)

Animal Vaccines Market Size Worth $26.12 Billion By 2030, Due To Growing Incidence Of Food-Borne Zoonotic Diseases And Increasing Animal Husbandry | Grand View Research, Inc.

“Grand View Research, Inc. – Market Research And Consulting” According to a new report published by Grand View Research, The increasing outbreaks of cattle disease and the ever-expanding livestock population are the prime factors for the wide acceptance of the ruminants especially cattle vaccines globally. Moreover, rising pet ownership and…

Continue Reading Animal Vaccines Market Size Worth $26.12 Billion By 2030, Due To Growing Incidence Of Food-Borne Zoonotic Diseases And Increasing Animal Husbandry | Grand View Research, Inc.